$GNMK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GenMark Diagnostics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GenMark Diagnostics, Inc.. Get notifications about new insider transactions in GenMark Diagnostics, Inc. for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Buy | M | 6.00 | 25,000 | 150,000 | 110,962 | 86 K to 111 K (+29.08 %) |
| Aug 19 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Sell | S | 6.51 | 16,150 | 105,137 | 85,962 | 102.1 K to 86 K (-15.82 %) |
| Aug 19 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Sell | S | 6.51 | 2,200 | 14,322 | 102,112 | 104.3 K to 102.1 K (-2.11 %) |
| Aug 08 2019 | GNMK | GenMark Diagnostic ... | McNally James B. | SVP, Marketing and ... | Sell | S | 5.87 | 1,006 | 5,905 | 260,223 | 261.2 K to 260.2 K (-0.39 %) |
| Aug 08 2019 | GNMK | GenMark Diagnostic ... | Mitchell Brian Andrew | SVP, Operations | Sell | S | 5.87 | 711 | 4,174 | 206,207 | 206.9 K to 206.2 K (-0.34 %) |
| Aug 08 2019 | GNMK | GenMark Diagnostic ... | Ek John Frederick | Chief Financial Off ... | Sell | S | 5.87 | 1,890 | 11,094 | 174,648 | 176.5 K to 174.6 K (-1.07 %) |
| Aug 02 2019 | GNMK | GenMark Diagnostic ... | Giles Lisa M. | Director | Grant | A | 0.00 | 702 | 0 | 59,437 | 58.7 K to 59.4 K (+1.20 %) |
| Jun 04 2019 | GNMK | GenMark Diagnostic ... | Fox James | Director | Grant | A | 0.00 | 25,889 | 0 | 161,596 | 135.7 K to 161.6 K (+19.08 %) |
| Jun 04 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 19,851 | 0 | 104,312 | 84.5 K to 104.3 K (+23.50 %) |
| Jun 04 2019 | GNMK | GenMark Diagnostic ... | Kagnoff Michael | Director | Grant | A | 0.00 | 17,339 | 0 | 108,216 | 90.9 K to 108.2 K (+19.08 %) |
| Jun 04 2019 | GNMK | GenMark Diagnostic ... | FAULKNER DARYL | Director | Grant | A | 0.00 | 18,655 | 0 | 105,788 | 87.1 K to 105.8 K (+21.41 %) |
| May 31 2019 | GNMK | GenMark Diagnostic ... | Ek John Frederick | Chief Financial Off ... | Sell | S | 6.60 | 924 | 6,098 | 176,538 | 177.5 K to 176.5 K (-0.52 %) |
| May 31 2019 | GNMK | GenMark Diagnostic ... | Stier Eric | SVP & General Couns ... | Sell | S | 6.60 | 1,564 | 10,322 | 237,552 | 239.1 K to 237.6 K (-0.65 %) |
| May 31 2019 | GNMK | GenMark Diagnostic ... | Ek John Frederick | Chief Financial Off ... | Sell | S | 6.60 | 924 | 6,098 | 176,538 | 177.5 K to 176.5 K (-0.52 %) |
| May 31 2019 | GNMK | GenMark Diagnostic ... | Stier Eric | SVP & General Couns ... | Sell | S | 6.60 | 1,564 | 10,322 | 237,552 | 239.1 K to 237.6 K (-0.65 %) |
| May 31 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 6.60 | 1,729 | 11,411 | 358,577 | 360.3 K to 358.6 K (-0.48 %) |
| May 31 2019 | GNMK | GenMark Diagnostic ... | McNally James B. | SVP, Marketing and ... | Sell | S | 6.60 | 2,057 | 13,576 | 261,229 | 263.3 K to 261.2 K (-0.78 %) |
| May 31 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Sell | S | 6.60 | 2,304 | 15,206 | 344,222 | 346.5 K to 344.2 K (-0.66 %) |
| May 31 2019 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Sell | S | 6.60 | 10,369 | 68,435 | 824,951 | 835.3 K to 825 K (-1.24 %) |
| May 31 2019 | GNMK | GenMark Diagnostic ... | Jensen Tyler | SVP, Engineering an ... | Sell | S | 6.60 | 825 | 5,445 | 134,211 | 135 K to 134.2 K (-0.61 %) |
| May 28 2019 | GNMK | GenMark Diagnostic ... | McNally James B. | SVP, Marketing and ... | Sell | S | 6.62 | 231 | 1,529 | 263,286 | 263.5 K to 263.3 K (-0.09 %) |
| May 28 2019 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Sell | S | 6.62 | 6,247 | 41,355 | 835,320 | 841.6 K to 835.3 K (-0.74 %) |
| May 28 2019 | GNMK | GenMark Diagnostic ... | Mitchell Brian Andrew | SVP, Operations | Sell | S | 6.62 | 231 | 1,529 | 208,647 | 208.9 K to 208.6 K (-0.11 %) |
| May 28 2019 | GNMK | GenMark Diagnostic ... | Stier Eric | SVP & General Couns ... | Sell | S | 6.62 | 986 | 6,527 | 239,116 | 240.1 K to 239.1 K (-0.41 %) |
| May 28 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Sell | S | 6.62 | 1,371 | 9,076 | 346,526 | 347.9 K to 346.5 K (-0.39 %) |
| May 28 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 6.62 | 1,029 | 6,812 | 360,306 | 361.3 K to 360.3 K (-0.28 %) |
| May 24 2019 | GNMK | GenMark Diagnostic ... | Jensen Tyler | SVP, Engineering an ... | Sell | S | 6.85 | 313 | 2,144 | 135,036 | 135.3 K to 135 K (-0.23 %) |
| May 24 2019 | GNMK | GenMark Diagnostic ... | Ek John Frederick | Chief Financial Off ... | Sell | S | 6.85 | 501 | 3,432 | 177,462 | 178 K to 177.5 K (-0.28 %) |
| May 22 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Sell | S | 6.83 | 1,907 | 13,025 | 347,897 | 349.8 K to 347.9 K (-0.55 %) |
| May 22 2019 | GNMK | GenMark Diagnostic ... | Ek John Frederick | Chief Financial Off ... | Sell | S | 6.83 | 495 | 3,381 | 177,963 | 178.5 K to 178 K (-0.28 %) |
| May 22 2019 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Sell | S | 6.83 | 7,837 | 53,527 | 841,567 | 849.4 K to 841.6 K (-0.92 %) |
| May 22 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 6.83 | 1,766 | 12,062 | 361,335 | 363.1 K to 361.3 K (-0.49 %) |
| May 22 2019 | GNMK | GenMark Diagnostic ... | Jensen Tyler | SVP, Engineering an ... | Sell | S | 6.83 | 309 | 2,110 | 135,349 | 135.7 K to 135.3 K (-0.23 %) |
| May 22 2019 | GNMK | GenMark Diagnostic ... | Stier Eric | SVP & General Couns ... | Sell | S | 6.83 | 1,652 | 11,283 | 240,102 | 241.8 K to 240.1 K (-0.68 %) |
| May 20 2019 | GNMK | GenMark Diagnostic ... | Mitchell Brian Andrew | SVP, Operations | Sell | S | 7.01 | 448 | 3,140 | 208,878 | 209.3 K to 208.9 K (-0.21 %) |
| May 07 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 8.00 | 10,000 | 80,000 | 363,101 | 373.1 K to 363.1 K (-2.68 %) |
| May 06 2019 | GNMK | GenMark Diagnostic ... | Mitchell Brian Andrew | SVP, Operations | Sell | S | 7.79 | 654 | 5,095 | 209,326 | 210 K to 209.3 K (-0.31 %) |
| May 06 2019 | GNMK | GenMark Diagnostic ... | McNally James B. | SVP, Sales and Mark ... | Sell | S | 7.79 | 928 | 7,229 | 263,517 | 264.4 K to 263.5 K (-0.35 %) |
| Apr 16 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 7.51 | 10,000 | 75,100 | 373,101 | 383.1 K to 373.1 K (-2.61 %) |
| Mar 01 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 7.84 | 18,464 | 144,758 | 383,101 | 401.6 K to 383.1 K (-4.60 %) |
| Mar 01 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 7.96 | 26,704 | 212,564 | 401,565 | 428.3 K to 401.6 K (-6.24 %) |
| Feb 27 2019 | GNMK | GenMark Diagnostic ... | Stier Eric | SVP & General Couns ... | Sell | S | 6.80 | 11,243 | 76,452 | 241,754 | 253 K to 241.8 K (-4.44 %) |
| Feb 27 2019 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Sell | S | 6.79 | 54,596 | 370,707 | 849,404 | 904 K to 849.4 K (-6.04 %) |
| Feb 27 2019 | GNMK | GenMark Diagnostic ... | Ek John Frederick | Chief Financial Off ... | Sell | S | 6.79 | 5,205 | 35,342 | 178,458 | 183.7 K to 178.5 K (-2.83 %) |
| Feb 27 2019 | GNMK | GenMark Diagnostic ... | Mitchell Brian Andrew | SVP, Operations | Sell | S | 6.79 | 10,996 | 74,663 | 209,980 | 221 K to 210 K (-4.98 %) |
| Feb 27 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Sell | S | 6.80 | 11,410 | 77,588 | 349,804 | 361.2 K to 349.8 K (-3.16 %) |
| Feb 27 2019 | GNMK | GenMark Diagnostic ... | McNally James B. | SVP, Sales and Mark ... | Sell | S | 6.79 | 12,297 | 83,497 | 264,445 | 276.7 K to 264.4 K (-4.44 %) |
| Feb 27 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 6.79 | 12,097 | 82,139 | 428,269 | 440.4 K to 428.3 K (-2.75 %) |
| Feb 21 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Option Exercise | A | 0.00 | 42,500 | 0 | 42,500 | |
| Feb 21 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Sell | S | 6.16 | 2,063 | 12,708 | 361,214 | 363.3 K to 361.2 K (-0.57 %) |
| Feb 21 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Grant | A | 0.00 | 127,500 | 0 | 363,277 | 235.8 K to 363.3 K (+54.08 %) |
| Feb 21 2019 | GNMK | GenMark Diagnostic ... | McNally James B. | SVP, Sales and Mark ... | Option Exercise | A | 0.00 | 33,750 | 0 | 33,750 | |
| Feb 21 2019 | GNMK | GenMark Diagnostic ... | McNally James B. | SVP, Sales and Mark ... | Grant | A | 0.00 | 101,250 | 0 | 276,742 | 175.5 K to 276.7 K (+57.69 %) |
| Feb 21 2019 | GNMK | GenMark Diagnostic ... | Mitchell Brian Andrew | SVP, Operations | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Feb 21 2019 | GNMK | GenMark Diagnostic ... | Mitchell Brian Andrew | SVP, Operations | Sell | S | 6.32 | 519 | 3,280 | 220,976 | 221.5 K to 221 K (-0.23 %) |
| Feb 21 2019 | GNMK | GenMark Diagnostic ... | Mitchell Brian Andrew | SVP, Operations | Grant | A | 0.00 | 75,000 | 0 | 221,495 | 146.5 K to 221.5 K (+51.20 %) |
| Feb 21 2019 | GNMK | GenMark Diagnostic ... | Stier Eric | SVP & General Couns ... | Option Exercise | A | 0.00 | 23,750 | 0 | 23,750 | |
| Feb 21 2019 | GNMK | GenMark Diagnostic ... | Stier Eric | SVP & General Couns ... | Sell | S | 6.16 | 1,986 | 12,234 | 252,997 | 255 K to 253 K (-0.78 %) |
| Feb 21 2019 | GNMK | GenMark Diagnostic ... | Stier Eric | SVP & General Couns ... | Grant | A | 0.00 | 71,250 | 0 | 254,983 | 183.7 K to 255 K (+38.78 %) |
| Feb 21 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Feb 21 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 6.16 | 2,121 | 13,065 | 440,366 | 442.5 K to 440.4 K (-0.48 %) |
| Feb 21 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Grant | A | 0.00 | 75,000 | 0 | 442,487 | 367.5 K to 442.5 K (+20.41 %) |
| Feb 21 2019 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Option Exercise | A | 0.00 | 217,500 | 0 | 217,500 | |
| Feb 21 2019 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Sell | S | 6.16 | 5,562 | 34,262 | 904,000 | 909.6 K to 904 K (-0.61 %) |
| Feb 21 2019 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Grant | A | 0.00 | 217,500 | 0 | 909,562 | 692.1 K to 909.6 K (+31.43 %) |
| Feb 21 2019 | GNMK | GenMark Diagnostic ... | Ek John Frederick | Chief Financial Off ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Feb 21 2019 | GNMK | GenMark Diagnostic ... | Ek John Frederick | Chief Financial Off ... | Sell | S | 6.16 | 595 | 3,665 | 183,663 | 184.3 K to 183.7 K (-0.32 %) |
| Feb 21 2019 | GNMK | GenMark Diagnostic ... | Ek John Frederick | Chief Financial Off ... | Grant | A | 0.00 | 75,000 | 0 | 184,258 | 109.3 K to 184.3 K (+68.64 %) |
| Jan 25 2019 | GNMK | GenMark Diagnostic ... | Stier Eric | SVP & General Couns ... | Sell | S | 5.90 | 3,596 | 21,216 | 183,733 | 187.3 K to 183.7 K (-1.92 %) |
| Jan 25 2019 | GNMK | GenMark Diagnostic ... | McNally James B. | SVP, Sales and Mark ... | Sell | S | 5.90 | 4,730 | 27,907 | 175,492 | 180.2 K to 175.5 K (-2.62 %) |
| Jan 25 2019 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Sell | S | 5.90 | 15,166 | 89,479 | 692,062 | 707.2 K to 692.1 K (-2.14 %) |
| Jan 25 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 5.90 | 3,974 | 23,447 | 367,487 | 371.5 K to 367.5 K (-1.07 %) |
| Jan 25 2019 | GNMK | GenMark Diagnostic ... | Mitchell Brian Andrew | SVP, Operations | Sell | S | 5.90 | 3,974 | 23,447 | 146,495 | 150.5 K to 146.5 K (-2.64 %) |
| Jan 25 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 5.90 | 5,297 | 31,252 | 235,777 | 241.1 K to 235.8 K (-2.20 %) |
| Jan 22 2019 | GNMK | GenMark Diagnostic ... | Mitchell Brian Andrew | SVP, Operations | Option Exercise | M | 0.00 | 9,600 | 0 | 16,650 | |
| Jan 22 2019 | GNMK | GenMark Diagnostic ... | Mitchell Brian Andrew | SVP, Operations | Buy | M | 0.00 | 9,600 | 0 | 150,469 | 140.9 K to 150.5 K (+6.81 %) |
| Jan 22 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Option Exercise | M | 0.00 | 9,600 | 0 | 16,650 | |
| Jan 22 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Buy | M | 0.00 | 9,600 | 0 | 371,461 | 361.9 K to 371.5 K (+2.65 %) |
| Jan 22 2019 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Option Exercise | M | 0.00 | 40,229 | 0 | 69,771 | |
| Jan 22 2019 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Option Exercise | M | 0.00 | 40,229 | 0 | 69,771 | |
| Jan 22 2019 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Buy | M | 0.00 | 40,229 | 0 | 707,228 | 667 K to 707.2 K (+6.03 %) |
| Jan 22 2019 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Buy | M | 0.00 | 40,229 | 0 | 707,228 | 667 K to 707.2 K (+6.03 %) |
| Jan 22 2019 | GNMK | GenMark Diagnostic ... | McNally James B. | SVP, Sales and Mark ... | Option Exercise | M | 0.00 | 11,428 | 0 | 19,822 | |
| Jan 22 2019 | GNMK | GenMark Diagnostic ... | McNally James B. | SVP, Sales and Mark ... | Option Exercise | M | 0.00 | 11,428 | 0 | 19,822 | |
| Jan 22 2019 | GNMK | GenMark Diagnostic ... | McNally James B. | SVP, Sales and Mark ... | Buy | M | 0.00 | 11,428 | 0 | 180,222 | 168.8 K to 180.2 K (+6.77 %) |
| Jan 22 2019 | GNMK | GenMark Diagnostic ... | McNally James B. | SVP, Sales and Mark ... | Buy | M | 0.00 | 11,428 | 0 | 180,222 | 168.8 K to 180.2 K (+6.77 %) |
| Jan 22 2019 | GNMK | GenMark Diagnostic ... | Stier Eric | SVP & General Couns ... | Option Exercise | M | 0.00 | 8,685 | 0 | 15,065 | |
| Jan 22 2019 | GNMK | GenMark Diagnostic ... | Stier Eric | SVP & General Couns ... | Option Exercise | M | 0.00 | 8,685 | 0 | 15,065 | |
| Jan 22 2019 | GNMK | GenMark Diagnostic ... | Stier Eric | SVP & General Couns ... | Buy | M | 0.00 | 8,685 | 0 | 187,329 | 178.6 K to 187.3 K (+4.86 %) |
| Jan 22 2019 | GNMK | GenMark Diagnostic ... | Stier Eric | SVP & General Couns ... | Buy | M | 0.00 | 8,685 | 0 | 187,329 | 178.6 K to 187.3 K (+4.86 %) |
| Jan 22 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Option Exercise | M | 0.00 | 12,800 | 0 | 22,200 | |
| Jan 22 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Buy | M | 0.00 | 12,800 | 0 | 241,074 | 228.3 K to 241.1 K (+5.61 %) |
| Nov 29 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 5.08 | 970 | 4,928 | 361,861 | 362.8 K to 361.9 K (-0.27 %) |
| Nov 29 2018 | GNMK | GenMark Diagnostic ... | Stier Eric | SVP & General Couns ... | Sell | S | 5.08 | 930 | 4,724 | 178,644 | 179.6 K to 178.6 K (-0.52 %) |
| Nov 29 2018 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Sell | S | 5.08 | 5,884 | 29,891 | 666,999 | 672.9 K to 667 K (-0.87 %) |
| Nov 29 2018 | GNMK | GenMark Diagnostic ... | Mitchell Brian Andrew | SVP, Operations | Sell | S | 5.08 | 219 | 1,113 | 140,869 | 141.1 K to 140.9 K (-0.16 %) |
| Nov 29 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 5.08 | 1,292 | 6,563 | 228,274 | 229.6 K to 228.3 K (-0.56 %) |
| Nov 29 2018 | GNMK | GenMark Diagnostic ... | McNally James B. | SVP, Sales and Mark ... | Sell | S | 5.08 | 219 | 1,113 | 168,794 | 169 K to 168.8 K (-0.13 %) |
| Nov 26 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 4.84 | 1,814 | 8,780 | 362,831 | 364.6 K to 362.8 K (-0.50 %) |
| Nov 26 2018 | GNMK | GenMark Diagnostic ... | Stier Eric | SVP & General Couns ... | Sell | S | 4.84 | 1,697 | 8,213 | 179,574 | 181.3 K to 179.6 K (-0.94 %) |
| Nov 26 2018 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Sell | S | 4.84 | 8,047 | 38,947 | 672,883 | 680.9 K to 672.9 K (-1.18 %) |
| Nov 26 2018 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Sell | S | 4.84 | 8,047 | 38,947 | 672,883 | 680.9 K to 672.9 K (-1.18 %) |
| Nov 26 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 4.84 | 1,959 | 9,482 | 229,566 | 231.5 K to 229.6 K (-0.85 %) |
| Nov 26 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 4.84 | 1,959 | 9,482 | 229,566 | 231.5 K to 229.6 K (-0.85 %) |
| Nov 20 2018 | GNMK | GenMark Diagnostic ... | Mitchell Brian Andrew | SVP, Operations | Sell | S | 4.99 | 418 | 2,086 | 141,088 | 141.5 K to 141.1 K (-0.30 %) |
| Nov 06 2018 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Sell | S | 4.85 | 1,561 | 7,571 | 680,930 | 682.5 K to 680.9 K (-0.23 %) |
| Nov 06 2018 | GNMK | GenMark Diagnostic ... | Stier Eric | SVP & General Couns ... | Sell | S | 4.85 | 350 | 1,698 | 181,271 | 181.6 K to 181.3 K (-0.19 %) |
| Nov 06 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 4.85 | 382 | 1,853 | 364,645 | 365 K to 364.6 K (-0.10 %) |
| Nov 06 2018 | GNMK | GenMark Diagnostic ... | Mitchell Brian Andrew | SVP, Operations | Sell | S | 4.85 | 683 | 3,313 | 141,506 | 142.2 K to 141.5 K (-0.48 %) |
| Nov 06 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 4.85 | 226 | 1,096 | 231,525 | 231.8 K to 231.5 K (-0.10 %) |
| Nov 06 2018 | GNMK | GenMark Diagnostic ... | McNally James B. | SVP, Sales and Mark ... | Sell | S | 4.85 | 1,644 | 7,973 | 169,013 | 170.7 K to 169 K (-0.96 %) |
| Oct 30 2018 | GNMK | GenMark Diagnostic ... | McNally James B. | SVP, Sales and Mark ... | Grant | A | 0.00 | 20,000 | 0 | 170,657 | 150.7 K to 170.7 K (+13.28 %) |
| Aug 27 2018 | GNMK | GenMark Diagnostic ... | McNally James B. | SVP, Marketing & Bu ... | Sell | S | 7.16 | 230 | 1,647 | 150,657 | 150.9 K to 150.7 K (-0.15 %) |
| Aug 27 2018 | GNMK | GenMark Diagnostic ... | Mitchell Brian Andrew | SVP, Operations | Sell | S | 7.16 | 230 | 1,647 | 142,189 | 142.4 K to 142.2 K (-0.16 %) |
| Aug 27 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 7.16 | 1,022 | 7,318 | 365,027 | 366 K to 365 K (-0.28 %) |
| Aug 27 2018 | GNMK | GenMark Diagnostic ... | Williams Jennifer Anne | SVP, Human Resource ... | Sell | S | 7.16 | 1,064 | 7,618 | 193,366 | 194.4 K to 193.4 K (-0.55 %) |
| Aug 27 2018 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Sell | S | 7.16 | 6,203 | 44,413 | 682,491 | 688.7 K to 682.5 K (-0.90 %) |
| Aug 27 2018 | GNMK | GenMark Diagnostic ... | Stier Eric | SVP & General Couns ... | Sell | S | 7.16 | 979 | 7,010 | 181,621 | 182.6 K to 181.6 K (-0.54 %) |
| Aug 27 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 7.16 | 1,361 | 9,745 | 231,751 | 233.1 K to 231.8 K (-0.58 %) |
| Aug 22 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 7.39 | 1,915 | 14,152 | 233,112 | 235 K to 233.1 K (-0.81 %) |
| Aug 22 2018 | GNMK | GenMark Diagnostic ... | Williams Jennifer Anne | SVP, Human Resource ... | Sell | S | 7.39 | 1,809 | 13,369 | 194,430 | 196.2 K to 194.4 K (-0.92 %) |
| Aug 22 2018 | GNMK | GenMark Diagnostic ... | Stier Eric | SVP & General Couns ... | Sell | S | 7.39 | 1,659 | 12,260 | 182,600 | 184.3 K to 182.6 K (-0.90 %) |
| Aug 22 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 7.39 | 1,774 | 13,110 | 366,049 | 367.8 K to 366 K (-0.48 %) |
| Aug 22 2018 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Sell | S | 7.39 | 6,010 | 44,414 | 688,694 | 694.7 K to 688.7 K (-0.87 %) |
| Aug 20 2018 | GNMK | GenMark Diagnostic ... | Mitchell Brian Andrew | SVP, Operations | Sell | S | 7.40 | 426 | 3,152 | 142,419 | 142.8 K to 142.4 K (-0.30 %) |
| Aug 07 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 7.20 | 207 | 1,490 | 235,027 | 235.2 K to 235 K (-0.09 %) |
| Aug 07 2018 | GNMK | GenMark Diagnostic ... | McNally James B. | SVP, Marketing & Bu ... | Sell | S | 7.20 | 680 | 4,896 | 150,887 | 151.6 K to 150.9 K (-0.45 %) |
| Aug 07 2018 | GNMK | GenMark Diagnostic ... | Mitchell Brian Andrew | SVP, Operations | Sell | S | 7.20 | 628 | 4,522 | 142,845 | 143.5 K to 142.8 K (-0.44 %) |
| Aug 06 2018 | GNMK | GenMark Diagnostic ... | Williams Jennifer Anne | SVP, Human Resource ... | Sell | S | 7.20 | 293 | 2,110 | 196,239 | 196.5 K to 196.2 K (-0.15 %) |
| Aug 06 2018 | GNMK | GenMark Diagnostic ... | Stier Eric | SVP & General Couns ... | Sell | S | 7.20 | 322 | 2,318 | 184,259 | 184.6 K to 184.3 K (-0.17 %) |
| Aug 06 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 7.20 | 351 | 2,527 | 367,823 | 368.2 K to 367.8 K (-0.10 %) |
| Aug 06 2018 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Sell | S | 7.20 | 1,004 | 7,229 | 694,704 | 695.7 K to 694.7 K (-0.14 %) |
| May 29 2018 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 18,866 | 0 | 84,461 | 65.6 K to 84.5 K (+28.76 %) |
| May 29 2018 | GNMK | GenMark Diagnostic ... | FAULKNER DARYL | Director | Grant | A | 0.00 | 17,714 | 0 | 87,133 | 69.4 K to 87.1 K (+25.52 %) |
| May 29 2018 | GNMK | GenMark Diagnostic ... | Giles Lisa M. | Director | Grant | A | 0.00 | 17,107 | 0 | 40,798 | 23.7 K to 40.8 K (+72.21 %) |
| May 29 2018 | GNMK | GenMark Diagnostic ... | Kagnoff Michael | Director | Grant | A | 0.00 | 16,464 | 0 | 90,877 | 74.4 K to 90.9 K (+22.13 %) |
| May 29 2018 | GNMK | GenMark Diagnostic ... | Fox James | Director | Grant | A | 0.00 | 24,625 | 0 | 135,707 | 111.1 K to 135.7 K (+22.17 %) |
| May 24 2018 | GNMK | GenMark Diagnostic ... | Stier Eric | SVP & General Couns ... | Sell | S | 6.88 | 944 | 6,495 | 184,581 | 185.5 K to 184.6 K (-0.51 %) |
| May 24 2018 | GNMK | GenMark Diagnostic ... | Williams Jennifer Anne | SVP, Human Resource ... | Sell | S | 6.88 | 1,025 | 7,052 | 195,032 | 196.1 K to 195 K (-0.52 %) |
| May 24 2018 | GNMK | GenMark Diagnostic ... | Mitchell Brian Andrew | SVP, Operations | Sell | S | 6.88 | 216 | 1,486 | 141,973 | 142.2 K to 142 K (-0.15 %) |
| May 24 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 6.88 | 1,312 | 9,027 | 235,234 | 236.5 K to 235.2 K (-0.55 %) |
| May 24 2018 | GNMK | GenMark Diagnostic ... | McNally James B. | SVP, Marketing & Bu ... | Sell | S | 6.88 | 216 | 1,486 | 150,595 | 150.8 K to 150.6 K (-0.14 %) |
| May 24 2018 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Sell | S | 6.88 | 4,168 | 28,676 | 694,208 | 698.4 K to 694.2 K (-0.60 %) |
| May 24 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 6.88 | 984 | 6,770 | 366,674 | 367.7 K to 366.7 K (-0.27 %) |
| May 22 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 6.91 | 1,904 | 13,157 | 236,546 | 238.5 K to 236.5 K (-0.80 %) |
| May 22 2018 | GNMK | GenMark Diagnostic ... | Stier Eric | SVP & General Couns ... | Sell | S | 6.91 | 1,648 | 11,388 | 185,525 | 187.2 K to 185.5 K (-0.88 %) |
| May 22 2018 | GNMK | GenMark Diagnostic ... | Williams Jennifer Anne | SVP, Human Resource ... | Sell | S | 6.91 | 1,799 | 12,431 | 196,057 | 197.9 K to 196.1 K (-0.91 %) |
| May 22 2018 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Sell | S | 6.91 | 5,459 | 37,722 | 698,376 | 703.8 K to 698.4 K (-0.78 %) |
| May 22 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 6.91 | 1,764 | 12,189 | 367,658 | 369.4 K to 367.7 K (-0.48 %) |
| May 18 2018 | GNMK | GenMark Diagnostic ... | Williams Jennifer Anne | SVP, Human Resource ... | Sell | S | 6.90 | 23,688 | 163,447 | 197,856 | 221.5 K to 197.9 K (-10.69 %) |